ArticleJournal of gastroenterology and hepatology2026
Efficacy of a Dairy-Free Diet in Adult Patients With Eosinophilic Esophagitis: A Pilot Prospective Multicenter Study.
Article in Journal of gastroenterology and hepatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Dietary Approaches in Eosinophilic Esophagitis.Nutrients · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
Abstract
backgroundEosinophilic esophagitis (EoE) is a chronic, immune-mediated disease in which elimination diets represent an effective therapeutic option. Although six-food elimination diets (6-FED) achieve high remission rates, their complexity often compromises adherence. Dairy-free diet (DFD) has emerged as a simpler alternative, yet evidence in adult populations remains limited.
aimsTo evaluate the clinical, endoscopic, and histological outcomes of a 12-week DFD in adult patients with EoE and to explore potential predictors of histological remission and dietary adherence.
methodsWe conducted a prospective, multicenter, open label, single-arm interventional study across five Italian referral centers, enrolling 31 adults with active EoE. Participants followed a 12-week DFD, after which clinical symptoms (EEsAI), disease severity (I-SEE), endoscopic findings (EREFS), quality of life (EoE-QOL-A), and adherence (VAS scale) were assessed.
resultsTwenty-eight patients completed the 12-week protocol. Histological remission was achieved in 53.6% of patients (intention-to-treat: 48.4%); among these, 86.7% also reached clinical remission. The median EEsAI improved from 35 to 18.5 (p = 0.009) and the median I-SEE score from 6.5 to 4 (p < 0.0001). Quality of life improved (median EoE-QoL-A from 36.5 to 52, p = 0.02), and adherence was high (median VAS 8 [IQR 7-9.5]). Predictors of lower histological response included previous esophageal dilations and higher baseline exudate and eosinophil counts. Male sex and higher BMI predicted lower adherence.
conclusionsIn this exploratory multicenter prospective study, DFD induced histological remission in more than half of patients and clinically meaningful improvements in symptoms, disease severity, endoscopy, and quality of life.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.